Evidence map›Paper›PMID 35145902›Full record

ArticleFrontiers in oncology2021

Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors.

Liangyou Gu, Wenlei Zhao, Junnan Xu, Baojun Wang, Qiang Cheng, Donglai Shen, Yundong Xuan, Xupeng Zhao, Hongzhao Li, Xin Ma and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Liangyou GuDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Wenlei ZhaoDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Junnan XuDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Baojun WangDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Qiang ChengDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Donglai ShenDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Yundong XuanDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Xupeng ZhaoDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Hongzhao LiDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Xin MaDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Xu ZhangDepartment of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe compared the outcomes of transperitoneal robotic partial nephrectomy (TRPN) and retroperitoneal robotic partial nephrectomy (RRPN) for complete upper pole renal masses (1 point for the "L" component of the RENAL scoring system). MATERIAL AND

methodsWe retrospectively reviewed patients who underwent either TRPN or RRPN from 2013 to 2016. Baseline demographics and perioperative, functional, and oncological results were compared. Multivariable analysis was performed to identify factors related to pentafecta achievement (ischemia time ≤25 min, negative margin, perioperative complication free, glomerular filtration rate (eGFR) preservation >90%, and no chronic kidney disease upstaging).

resultsNo significant differences between TRPN

conclusionsFor completely upper pole renal masses, both TRPN and RRPN have good and comparable results. Both surgical approaches remain viable options in the treatment of these cases.

Indexed as

kidney neoplasmsoutcomepartial nephrectomyroboticsupper pole

Identifiers

PMID35145902
PMCPMC8821917
OpenAlexW4210499156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.